Private equity has come out fighting against the U.S. Department of Justice (DOJ), Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC) as the collective agencies continue to look for ways to limit private equity’s ability to invest in the healthcare industry—despite a Texas court dismissing the FTC’s case against Welsh Carson Anderson & Stowe that had been brought in September 2023.
Read the full article: Healthcare Private Equity Investors Tackle Regulatory Challenges //
Source: https://middlemarketgrowth.org/healthcare-private-equity-antitrust-regulation/